HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Youngjoo Lee Selected Research

Youngjoo Lee Research Topics

Disease

13Lung Neoplasms (Lung Cancer)
03/2022 - 03/2012
13Neoplasms (Cancer)
12/2021 - 07/2014
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 01/2015
4Disease Progression
02/2022 - 07/2014
4Breast Neoplasms (Breast Cancer)
07/2019 - 01/2009
4Neoplasm Metastasis (Metastasis)
10/2017 - 03/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2022 - 01/2021
3Brain Neoplasms (Brain Tumor)
01/2022 - 01/2017
3Adenocarcinoma of Lung
11/2020 - 12/2012
3Hypoxia (Hypoxemia)
02/2012 - 03/2011
2Adenocarcinoma
04/2022 - 10/2013
2Pneumonia (Pneumonitis)
01/2022 - 01/2021
2Body Weight (Weight, Body)
01/2018 - 01/2016
2Exanthema (Rash)
10/2017 - 03/2012
2Inflammation (Inflammations)
01/2016 - 06/2012
1Esophageal Neoplasms (Esophageal Cancer)
04/2022
1Hypertrophy
01/2022
1Growth Disorders
01/2022
1Gastritis
01/2022
1Lymphatic Metastasis
01/2021
1Hyperinsulinism (Hyperinsulinemia)
01/2021
1Meningeal Carcinomatosis
01/2021
1Organizing Pneumonia
01/2020
1Infections
12/2019
1Neuroblastoma
01/2019
1Carcinogenesis
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
11/2018
1Hyperlipidemias (Hyperlipidemia)
03/2017
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2017
1Neurocysticercosis
01/2017
1Obesity
01/2016
1Type 2 Diabetes Mellitus (MODY)
01/2016
1Dyslipidemias (Dyslipidemia)
01/2016
1Angiomyolipoma
09/2015
1Nocardia Infections
12/2014

Drug/Important Bio-Agent (IBA)

9Tyrosine Kinase InhibitorsIBA
11/2020 - 03/2012
7Gefitinib (Iressa)FDA Link
03/2022 - 03/2012
6ErbB Receptors (EGF Receptor)IBA
01/2017 - 03/2012
5Pharmaceutical PreparationsIBA
01/2022 - 03/2014
4Immune Checkpoint InhibitorsIBA
02/2022 - 12/2020
4Cisplatin (Platino)FDA LinkGeneric
11/2020 - 12/2012
3Biomarkers (Surrogate Marker)IBA
05/2021 - 12/2012
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2016
3Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2017 - 03/2012
2pembrolizumabIBA
12/2021 - 12/2020
2DNA (Deoxyribonucleic Acid)IBA
10/2021 - 01/2015
2Metformin (Glucophage)FDA LinkGeneric
01/2021 - 01/2018
2Pemetrexed (MTA)FDA Link
01/2021 - 11/2020
2Hormones (Hormone)IBA
07/2019 - 04/2011
2GemcitabineFDA Link
10/2013 - 12/2012
2IronIBA
06/2012 - 06/2011
2Estrogen ReceptorsIBA
04/2011 - 03/2011
2Messenger RNA (mRNA)IBA
04/2011 - 01/2009
1Circulating Tumor DNAIBA
03/2022
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2022
1lazertinibIBA
01/2022
1Complement C7 (Complement 7)IBA
12/2021
1capmatinibIBA
10/2021
1Phosphotransferases (Kinase)IBA
10/2021
1Glial Fibrillary Acidic ProteinIBA
05/2021
1PlatinumIBA
01/2021
1Insulin (Novolin)FDA Link
01/2021
1Cell-Free Nucleic AcidsIBA
01/2021
1Thymidylate SynthaseIBA
01/2021
1Cytotoxins (Cytolysins)IBA
01/2021
1CobaltIBA
01/2021
1FluorineIBA
12/2020
1NivolumabIBA
12/2020
1ceritinibIBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
12/2019
1human ERBB2 proteinIBA
07/2019
1Trastuzumab (Herceptin)FDA Link
07/2019
1Apoptosis Regulatory ProteinsIBA
01/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1IDF-11774IBA
11/2018
1Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA
11/2018
1LipidsIBA
01/2018
1Simvastatin (Zocor)FDA LinkGeneric
10/2017
1Irinotecan (Camptosar)FDA LinkGeneric
10/2017
1AfatinibIBA
10/2017
1CholesterolIBA
03/2017
1Anaplastic Lymphoma KinaseIBA
01/2017
1CrizotinibIBA
01/2017
1HM781-36BIBA
01/2017
1Atorvastatin (Lipitor)FDA Link
01/2016
1CytokinesIBA
01/2016
1Therapeutic UsesIBA
01/2016
1Rosuvastatin Calcium (Crestor)FDA Link
01/2016
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2016
1SteroidsIBA
12/2014

Therapy/Procedure

10Therapeutics
02/2022 - 03/2012
7Drug Therapy (Chemotherapy)
01/2021 - 12/2012
2Proton Therapy
04/2022 - 01/2021
2Radiotherapy
04/2022 - 01/2021
2Chemoradiotherapy
04/2022 - 10/2017
2Aftercare (After-Treatment)
01/2021 - 07/2014
1Neoadjuvant Therapy
04/2022
1Fecal Microbiota Transplantation
01/2018
1Cranial Irradiation
01/2017
1Nephrectomy
09/2015